Home » Newsletters » BioWorld Science

BioWorld Science

June 19, 2008

View Archived Issues

Responses seen with PF-00299804 in patients with advanced non-small cell lung cancer

Ardea Biosciences reports on gout and arthritis programs at EULAR

Data on GSK-1363089 in papillary renal carcinoma, gastric cancer presented

New agents for treating neurological disorders disclosed in recent NeuroSearch and reMYND patents

SkyePharma reports results from phase III efficacy study of Flutiform

US WorldMeds reports initial results from phase III clinical trial of lofexidine

PLx Pharma demonstrates bioequivalence with aspirin and PL-2100

Neurocrine completes six-month treatment phase in phase IIb trial of elagolix

GLP-1 Technosphere formulation enhances insulin release and lowers blood glucose in healthy subjects

Ghrelin agonist TZP-101 improves symptoms of gastroparesis in diabetic patients

Moderate improvement in rheumatoid arthritis symptoms with MAPK inhibitor VX-702

Phase I results reported for oncolytic compounds from Bristol-Myers Squibb

Protox granted orphan drug status in Europe for PRX-321 in brain cancer

Cipher's revised CIP-Tramadol ER NDA accepted for review by the FDA

Akesis announces positive results from phase IIa trial of AKP-020 in type 2 diabetes

Pivotal phase III Acurox trial meets primary endpoint

Recent Bristol-Myers Squibb patents report novel therapeutic agents for HCV infection

Novel antiinflammatory agents disclosed in joint AstraZeneca and Bayer Schering Pharma patent

ThromboGenics and BioInvent sign license agreement with Roche for anticancer drug TB-403

EMEA recommends that product information for Pfizer's Exubera include data on lung cancer

Hisamitsu and Kyowa enter joint sales agreement in Japan for HFT-290 for cancer pain

Aastrom to initiate phase II clinical trial of cardiac repair cells in DCM

Boehringer Ingelheim to acquire Actimis Pharmaceuticals

Huya completes pre-IND consultation meeting with the FDA for sulcardine sulfate

Nventa develops proprietary vaccine adjuvant, Poly-ICR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...